ArticleCureus2025
Usefulness of Cardiac Resynchronization Therapy Optimization Using Combined Electrocardiography and Echocardiography.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Optimization of cardiac resynchronization therapy (CRT) using a 12-lead electrocardiogram (ECG) alone may not sufficiently improve left ventricular (LV) function in all cases. Therefore, we aimed to investigate whether additional optimization using transthoracic echocardiography (TTE) could further enhance CRT efficacy. Methods Sixty-five patients who underwent CRT implantation between March 2018 and July 2022 at Sakakibara Heart Institute, Japan, were included in this study. Data were collected at three points: before optimization (point A), after ECG-based optimization (point B), and after TTE-based adjustments (point C). Results The mean age was 74±11 years (male: 78.4%). The PR interval was significantly prolonged at points B and C compared with that at point A. The QRS width narrowed significantly at point B (119±20 ms vs. 137±20 ms, p<0.01) but increased at point C (124±20 ms), approaching point A levels. Thirty-six patients achieved LV dyssynchrony improvement with ECG optimization alone, whereas 29 required TTE adjustments for further improvement. Patients needing TTE optimization had higher QRS width at point C than at point B. TTE adjustments significantly improved LV ejection fraction (28.1±6.8% to 31.5±8.0%, p=0.01) and reduced septal flash (46.2% to 15.4%, p=0.04). The need for TTE adjustments was similar to the usage of CRT devices with and without auto-adjustment functions. Conclusion TTE-based optimization enhances LV function and synchrony in cases where ECG-based adjustments alone are insufficient, highlighting the importance of TTE evaluation in CRT optimization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.